Skip to main content
Stevanato Group S.p.A. (STVN)
NYSE: STVN · Real-Time Price · USD
20.56
-0.78 (-3.66%)
Dec 20, 2024, 4:00 PM EST - Market closed

Stevanato Group Revenue

Stevanato Group had revenue of 277.87M EUR in the quarter ending September 30, 2024, with 2.38% growth. This brings the company's revenue in the last twelve months to 1.09B, up 3.53% year-over-year. In the year 2023, Stevanato Group had annual revenue of 1.09B with 10.34% growth.

Revenue (ttm)
1.09B EUR
Revenue Growth
+3.53%
P/S Ratio
4.54
Revenue / Employee
194,192 EUR
Employees
5,634
Market Cap
5.61B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.09B101.67M10.34%
Dec 31, 2022983.68M139.76M16.56%
Dec 31, 2021843.92M181.88M27.47%
Dec 31, 2020662.04M125.50M23.39%
Dec 31, 2019536.54M514.54M2,338.37%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.81B
Bausch + Lomb 4.68B
Elanco Animal Health 4.45B
Lantheus Holdings 1.50B
Halozyme Therapeutics 947.36M
Waystar Holding 906.14M
Ionis Pharmaceuticals 803.07M
Legend Biotech 520.18M
Revenue Rankings

STVN News

More News